Business · 26/10/2016
FDA Announces Draft Guidance for Developing Drugs to Treat Low Sexual Interest in Women
The FDA is releasing a draft guidance to help pharmaceutical companies develop treatments for low sexual interest, desire, and/or arousal in women, with a focus on phase 3 clinical trials.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →